Hologic Reports Fourth Quarter Earnings

Investing.com – Hologic (NASDAQ: HOLX) reported fourth quarter EPS of $1.01, matching the analyst estimate. Revenue for the quarter reached $987.9M, exceeding the consensus estimate of $978.27M.

Guidance

Hologic anticipates Q1 2025 EPS to be between $1.00 – $1.03, slightly below the analyst consensus of $1.03.

Hologic's stock closed at $83.72, reflecting a 0.40% increase over the last three months and a 21.92% rise in the past twelve months.

In the last 90 days, Hologic experienced 0 positive EPS revisions and 12 negative EPS revisions. For a detailed view of Hologic's stock performance in relation to earnings, check elsewhere.

According to InvestingPro, Hologic's Financial Health score indicates "great performance".

Stay informed on upcoming earnings reports by visiting Investing.com's earnings calendar.